Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

NASAL SPRAY 0.05%

Nasal Spray
$0.0778per ML
OTC

Strength

50 mg/100mL

Manufacturer

Sheffield Pharmaceuticals LLC

NDC

11527014055

Classification

Generic

Dosage Form

LIQUID

Route

NASAL

Last Updated

4/22/2026

Active Ingredients

OXYMETAZOLINE HYDROCHLORIDE

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M012

On Market Since

5/30/2014

Pharmacological Classes

Imidazolines
Increased Sympathetic Activity
Vasoconstriction
Vasoconstrictor

Price History

1W

0.0%

1M

+5.6%

3M

+10.2%

6M

+6.8%

1Y

N/A

3Y

N/A

5Y

N/A

All

+6.2%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

NASAL SPRAY 0.05%
Generic
36800030410•Topco Associates LLC
$0.0625
per ML
NASAL SPRAY 0.05%
Generic
36800081710•Topco Associates LLC
$0.0625
per ML
NASAL DECONGESTANT 0.05% SPRAY
Generic
51672203005•Taro Pharmaceuticals U.S.A. Inc.
$0.0625
per ML
NASAL DECONGESTANT 0.05% SPRAY
Generic
51672203003•Taro Pharmaceuticals U.S.A. Inc.
$0.0678
per ML
PHENTERMINE 37.5 MG TABLET
Generic
10702002501•KVK-Tech Inc.
$0.0694
per EA
PHENTERMINE 37.5 MG TABLET
Generic
10702002510•KVK-Tech Inc.
$0.0694
per EA
PHENTERMINE 37.5 MG TABLET
Generic
11534016001•Sunrise Pharmaceutical Inc.
$0.0694
per EA
PHENTERMINE 37.5 MG TABLET
Generic
11534016003•Sunrise Pharmaceutical Inc.
$0.0694
per EA
PHENTERMINE 37.5 MG TABLET
Generic
11534016030•Sunrise Pharmaceutical Inc.
$0.0694
per EA
PHENTERMINE 37.5 MG TABLET
Generic
43547040410•Solco Healthcare US LLC
$0.0694
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy